Avicenna Laboratories Inc. is a manufacturer of solid dosage form of drug products. Founded in 2003, the company has been supplying various drug products to domestic and international clients. Regulatory Affairs, Sales, Marketing and other administrative functions as well as Formulation R&D are conducted through our head office and laboratories in Tehran.   Material Management, Quality Control, and Manufacturing are located in two separate factories in Kaveh Industrial Park 90 km south of Tehran.

• 20,000 sq. meter complex includes R&D and QC laboratories, Material Management, Production, Packaging, Utilities, Water Treatment and raw material and finished product Warehouses.
• State-of-the-art equipment and all other requirements for the production of solid dosage forms of drugs
• Extensive water treatment facilities
• Consistently lower levels of BOD and COD of effluent water than those required by the Environmental Protection Agency

• Comprised of a core of Ph.D. chemists and Pham.Ds. with supporting technical staff (M.Sc., B.Sc.)
• Close ties with major academic institutions
• Over 300 US and international process and products patents granted to our scientists
• Development of non-infringing process patents based on client’s specifications

• State-of-the-art equipment such as HPLCs, GCs, UV, IR Atomic Absorption, etc.
• Access to high-end analytical instruments such as high resolution 1H and 13C NMR, Mass Spec, Single Crystal and Powder X-Ray through major academic institutions
• Material Management, Quality Control and Manufacturing based on validated procedures
• Continuing in-house and off-site training of personnel on quality-related issues

• Strict adherence to over 1000 comprehensive Standard Operating Procedures (SOPs)
• Strict adherence to cGMP guidelines as set by FDA and ICH
• Continuing in-house and off-site training of personnel on cGMP issues
• Engineering staff includes, Chemical, Mechanical and Electrical Engineers with supporting staff

• Plant Master File (Type I) and Drug Mater File (Type II) on all products
• Submission of the open portion of DMFs to clients for Regulatory Affairs
• DMF submission to Europe and Canada